A soluble NG2/CSPG4 fragment released from tumor cells or tumor-associated pericytes can stimulate endothelial cell migration in the tumor microenvironment by interacting with galectin-3 and α3β1 integrin on the endothelial surface [47]. This evidence concerns the gene CSPG4 and neoplasm.